Rohandeep Singh “Jumping Tomato Studio” Expands Globally: New Offices in the UK and Dubai Mark a Milestone in the Journey of Success

New Delhi (India), July 21: Jumping Tomato Studio, under the dynamic leadership of young entrepreneur and film producer Rohandeep Singh, is proud to announce the opening of its new offices in the UK and Dubai. This significant expansion marks a momentous step in the company’s journey of success and growth.

Founded a decade ago in India, Jumping Tomato Studio quickly emerged as a prominent production house, producing and distributing numerous successful films that captivated audiences nationwide. With a vision to explore new horizons and reach international audiences, the company is now set to venture into overseas markets.

The newly established offices in the UK and Dubai will serve as hubs for production activities and overseas distribution. Rohandeep Singh, with his innate passion for storytelling and a keen eye for innovation, aims to bring captivating Indian content to global audiences. The studio’s first international Production movie, “Dhundh, Blue Star , Majnu Mastana & many mores ” is already in the pipeline, promising to be a cinematic delight that transcends borders.

Reflecting on this momentous occasion, Rohandeep Singh shared his excitement, “Expanding Jumping Tomato Studio to the UK and Dubai is a dream come true for our team. We believe in the power of storytelling to connect people across cultures, and this expansion allows us to share our creative vision with audiences around the world.”

As they embark on this exciting new chapter, Jumping Tomato Studio remains steadfast in its mission to entertain, inspire, and create a lasting impact through the magic of cinema. With Rohandeep Singh at the helm, the studio is poised to continue its legacy of excellence while embracing the vast possibilities of the international film market.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Related Posts

Altcoin Season Check: Chainlink Up 13.7%, Cardano Down 10%, and $BULLSKI on Stage Two

Key Takeaways Chainlink rose 13.7% and Monero 5.0% across seven days, the two clear winners among the majors. Cardano fell 10.0%, Uniswap 18.5% and Pepe 11.5% over the same week,…

Chandan Healthcare Delivers Strong Q1 FY27; Total Income at ₹82 Cr, EBITDA Surges 42% YoY to ₹21 Cr, PAT Rises 30% YoY

Lucknow, (Uttar Pradesh) [India], August 18: Chandan Healthcare Limited (NSE – CHANDAN), – Chandan Healthcare Limited, one of the leading players in Diagnostic sector having Pan India presence, has announced…

You Missed

From Chicago to Monkhood: The Extraordinary Journey of Akhand Swami Ji

  • By
  • August 28, 2026
From Chicago to Monkhood: The Extraordinary Journey of Akhand Swami Ji

Star-Studded Launch Marks the Grand Opening of NINJANOS – Mira Road’s New Multi-Cuisine Café

  • By
  • August 27, 2026
Star-Studded Launch Marks the Grand Opening of NINJANOS – Mira Road’s New Multi-Cuisine Café

Global Business Excellence & Leadership Conclave 2026 Brings Together Business Leaders, Entrepreneurs and Innovators in Hyderabad

  • By
  • August 27, 2026
Global Business Excellence & Leadership Conclave 2026 Brings Together Business Leaders, Entrepreneurs and Innovators in Hyderabad

MP State Dental Council Launches ₹3 Lakh Accident Cover and ₹10 Lakh Professional Indemnity for Dentists

  • By
  • August 27, 2026
MP State Dental Council Launches ₹3 Lakh Accident Cover and ₹10 Lakh Professional Indemnity for Dentists

PR QUEEN: Dr. Piyali Roy Crowns Dr. Nidhi Ojha as Mrs. Universe India–USA 2026 to Represent India on the Global Stage

  • By
  • August 27, 2026
PR QUEEN: Dr. Piyali Roy Crowns Dr. Nidhi Ojha as Mrs. Universe India–USA 2026 to Represent India on the Global Stage

India is producing more health research. The bigger question is: how much of it is reaching patients?

  • By
  • August 27, 2026
India is producing more health research. The bigger question is: how much of it is reaching patients?